ARCT: Arcturus Therapeutics Holdings Inc.
Performance
ARCT +8.83%
Watchlist
Select an item
Summary
ARCT at a glance
ARCT returned +8.83% over the past year and -23.93% a year over five years. Its worst drop in that year was -44.71%, smaller than 30% of stocks on Redstone, and its Sharpe ratio of 0.46 beats 48% of stocks on Redstone. It pays no dividends.
Current Drawdown
-43.95%
Rolling Volatility
127.97%
Actions
Metrics
Risk Indicators
Alpha16.48%
Beta2.13x
Sharpe0.46
Sortino0.74
Omega1.08
Calmar0.20
Martin1.73
Profile
About ARCT
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $270M
- Listed
- May 2013
- Employees
- 111
- Headquarters
- San Diego, CA
- Website
- arcturusrx.com
Comparisons